Close Window

Digital Look Email A Friend

Gilead Sciences's Remdesivir may cut Covid-19 risk of death by 62%

Published by Alexander Bueso on 10th July 2020

(Sharecast News) - Gilead Sciences's Remdesivir antiviral treatment for the novel coronavirus may cut the risk of death by nearly two-thirds.

URL: http://www.digitallook.com/dl/news/story/30908168/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.